VAGLIO, AUGUSTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.716
AS - Asia 8.973
EU - Europa 7.570
SA - Sud America 2.199
AF - Africa 236
OC - Oceania 115
Continente sconosciuto - Info sul continente non disponibili 1
Totale 28.810
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.561
RU - Federazione Russa 3.740
CN - Cina 2.410
SG - Singapore 2.396
BR - Brasile 1.778
HK - Hong Kong 1.429
KR - Corea 1.080
IT - Italia 1.039
IE - Irlanda 952
VN - Vietnam 753
SE - Svezia 497
IN - India 336
PL - Polonia 274
DE - Germania 225
FI - Finlandia 200
AR - Argentina 173
FR - Francia 154
ID - Indonesia 125
GB - Regno Unito 119
AU - Australia 113
NL - Olanda 73
EC - Ecuador 69
JP - Giappone 69
JO - Giordania 67
BD - Bangladesh 65
MX - Messico 62
CH - Svizzera 57
CI - Costa d'Avorio 54
CA - Canada 52
ZA - Sudafrica 51
IQ - Iraq 47
PY - Paraguay 47
CO - Colombia 46
ES - Italia 44
UA - Ucraina 36
AT - Austria 32
TR - Turchia 29
BJ - Benin 26
BE - Belgio 25
MA - Marocco 25
VE - Venezuela 23
PE - Perù 21
CL - Cile 19
EG - Egitto 18
KE - Kenya 17
PK - Pakistan 17
TN - Tunisia 17
UY - Uruguay 15
UZ - Uzbekistan 15
IL - Israele 14
DO - Repubblica Dominicana 13
KZ - Kazakistan 13
BG - Bulgaria 12
AZ - Azerbaigian 11
AE - Emirati Arabi Uniti 10
CZ - Repubblica Ceca 9
SA - Arabia Saudita 9
AL - Albania 8
GR - Grecia 8
LT - Lituania 8
MK - Macedonia 8
PH - Filippine 8
TH - Thailandia 8
BO - Bolivia 7
DZ - Algeria 7
PT - Portogallo 7
RO - Romania 7
BH - Bahrain 6
CR - Costa Rica 6
IR - Iran 6
NP - Nepal 6
OM - Oman 6
SK - Slovacchia (Repubblica Slovacca) 6
SN - Senegal 6
HN - Honduras 5
LU - Lussemburgo 5
MY - Malesia 5
PS - Palestinian Territory 5
AM - Armenia 4
AO - Angola 4
DK - Danimarca 4
HR - Croazia 4
QA - Qatar 4
BY - Bielorussia 3
ET - Etiopia 3
GT - Guatemala 3
LB - Libano 3
LI - Liechtenstein 3
NG - Nigeria 3
PA - Panama 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
BB - Barbados 2
GE - Georgia 2
JM - Giamaica 2
KG - Kirghizistan 2
KH - Cambogia 2
LK - Sri Lanka 2
LV - Lettonia 2
NO - Norvegia 2
Totale 28.784
Salva come PNG Salva come JPEG
Città #
Santa Clara 2.416
Singapore 1.800
Hong Kong 1.211
Seoul 1.080
Ashburn 1.074
Hefei 1.051
Dublin 951
Fairfield 722
Beijing 334
San Jose 305
Ho Chi Minh City 302
Woodbridge 296
Chandler 292
Lawrence 281
Altamura 274
Moscow 266
Houston 265
Warsaw 263
Seattle 261
Cambridge 226
Los Angeles 211
Buffalo 204
Wilmington 184
Boston 178
Mumbai 178
The Dalles 169
Princeton 168
Florence 165
São Paulo 160
Ann Arbor 134
Helsinki 132
Hanoi 131
Kent 126
Dallas 122
Melbourne 109
Paris 81
Munich 76
San Diego 67
New York 64
Milan 63
Bengaluru 61
Jakarta 60
Shanghai 59
Rio de Janeiro 56
Abidjan 54
Chicago 51
Bern 49
Frankfurt am Main 42
Tokyo 41
Rome 40
Lappeenranta 38
Brasília 35
Da Nang 35
Boardman 34
Falls Church 34
Hillsboro 31
London 31
Medford 31
Redondo Beach 30
Guangzhou 29
Chennai 27
Turku 27
Belo Horizonte 26
Cotonou 26
Porto Alegre 26
West Jordan 26
Quito 25
Johannesburg 23
Norwalk 23
Brussels 22
Hải Dương 22
Toronto 22
Asunción 20
Bologna 20
Haiphong 20
Phoenix 20
Biên Hòa 19
Campinas 19
Fortaleza 19
Guarulhos 19
Guayaquil 19
Mexico City 19
Pune 19
Buenos Aires 18
Council Bluffs 18
Curitiba 18
Denver 18
Orem 18
Ribeirão Preto 18
Stockholm 18
Thái Bình 18
Vienna 18
Washington 18
Goiânia 17
Yubileyny 17
Nuremberg 16
Recife 16
Santo André 16
Sumaré 16
Andover 15
Totale 18.034
Salva come PNG Salva come JPEG
Nome #
Neutrophil Activation Promotes Fibrinogen Oxidation and Thrombus Formation in Behçet’s Disease 219
A Clinical Workflow for Cost-Saving High-Rate Diagnosis of Genetic Kidney Diseases 215
First report of FIP1L1-PDGFR alpha-positive eosinophilic granulomatosis with polyangiitis 214
Reverse phenotyping after whole-Exome sequencing in steroid-resistant nephrotic syndrome 208
ANCA-associated vasculitis in childhood: Recent advances 206
Benralizumab for eosinophilic granulomatosis with polyangiitis: a retrospective, multicentre, cohort study 205
A Large-Scale Genetic Analysis Reveals a Strong Contribution of the HLA Class II Region to Giant Cell Arteritis Susceptibility 203
IgG4-related disease: advances in pathophysiology and treatment 201
A Report of 2 Cases of Kidney Involvement in ADA2 Deficiency: Different Disease Phenotypes and the Tissue Response to Type I Interferon 198
Thrombosis in vasculitis: from pathogenesis to treatment 194
Brief Report: Rituximab for the treatment of adult-onset IgA vasculitis (Henoch-Schönlein purpura) 193
A large-scale genetic analysis reveals an autoimmune origin of idiopathic retroperitoneal fibrosis 189
EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update 184
Stem-Cell-Derived Circulating Progenitors Dysfunction in Behçet's Syndrome Patients Correlates With Oxidative Stress 177
IgG4-related disease and other fibro-inflammatory conditions 175
Multiorgan manifestations of COL4A1 and COL4A2 variants and proposal for a clinical management protocol 174
Threatening drug-drug interaction in a kidney transplant patient with Coronavirus Disease 2019 (COVID-19) 171
Association of serum C3 concentration and histologic signs of thrombotic microangiopathy with outcomes among patients with ANCA-associated renal vasculitis 169
OP0148 MEPOLIZUMAB FOR EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA): A RETROSPECTIVE REAL-WORLD EUROPEAN STUDY ON 142 PATIENTS 169
Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis (EGPA): a European multicenter observational study 167
Cardiac involvement in eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss syndrome): Prospective evaluation at a tertiary referral centre 165
A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis 165
The rise of complement in ANCA-associated vasculitis: from marginal player to target of modern therapy 163
Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts 160
Prognostic Factors and Long-Term Outcome with ANCA-Associated Kidney Vasculitis in Childhood 159
Genetics of ANCA-associated vasculitis: role in pathogenesis, classification and management 158
Fcγ-receptor 3B (FCGR3B) copy number variations in patients with eosinophilic granulomatosis with polyangiitis 158
P1813CLINICAL CHARACTERIZATION OF CONGENITAL SOLITARY FUNCTIONING KIDNEY IN CHILDREN 157
Clinical and Prognostic Significance of Serum IgG4 in Chronic Periaortitis. An Analysis of 113 Patients 156
Significance of PR3-ANCA Positivity in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss) 156
Fibrocytes in Chronic Periaortitis: A Novel Mechanism Linking Inflammation and Fibrosis 154
Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status 152
Adalimumab-Based Treatment Versus Disease-Modifying Antirheumatic Drugs for Venous Thrombosis in Behçet's Syndrome: A Retrospective Study of Seventy Patients With Vascular Involvement 152
EBV-Associated Leukoencephalopathy with Late Onset of Central Nervous System Lymphoma in a Kidney Transplant Recipient 151
Asbestos and Smoking as Risk Factors for Idiopathic Retroperitoneal Fibrosis 151
135. ATHERO-THROMBOTIC AND VENOUS EVENTS (AVTE) IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA): A MULTICENTRE STUDY OF 573 ITALIAN PATIENTS 149
Antineutrophil cytoplasmic antibody-associated vasculitides and IgG4-related disease: A new overlap syndrome 149
The Role of Rituximab in Primary Focal Segmental Glomerular Sclerosis of the Adult 148
Type I interferon-related kidney disorders 146
Sequential rituximab and mepolizumab in eosinophilic granulomatosis with polyangiitis (EGPA): a European multicentre observational study 146
Changing patterns in clinical-histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis 143
Gut Microbiota and Associated Mucosal Immune Response in Eosinophilic Granulomatosis with Polyangiitis (EGPA) 142
Rituximab for chronic periaortitis without evidence of IgG4-related disease: A long-term follow-up study of 20 patients 142
Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome) 141
At the Heart of Eosinophilic Granulomatosis with Polyangiitis: into Cardiac and Vascular Involvement 140
Clinical phenotypes and long-term outcome of kidney involvement in Erdheim-Chester histiocytosis 140
Association of a polymorphism of the Fcγ-receptor 2A (FCGR2A) gene with chronic periaortitis 140
Eosinophilic granulomatosis with polyangiitis: Understanding the disease and its management 140
Cluster Analysis to Explore Clinical Subphenotypes of Eosinophilic Granulomatosis With Polyangiitis 139
298. RITUXIMAB FOR DIFFICULT-TO-TREAT CHRONIC PARIAORTITIS: A CASE-SERIES OF 20 PATIENTS 139
A TNFSF13B Functional Variant Is Not Involved in Systemic Sclerosis and Giant Cell Arteritis Susceptibility 138
Association between age at disease onset of anti-neutrophil cytoplasmic antibody-associated vasculitis and clinical presentation and short-term outcomes 138
Kidney involvement in Rosai-Dorfman disease 136
Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): cross-sectional analysis 136
Adult-onset IgA vasculitis (Henoch-Schönlein): Update on therapy 136
Erdheim–Chester disease: a rapidly evolving disease model 135
Rare Onset of Erdheim-Chester Disease in Children and Young Adults: A Case Series and Review of the Literature 134
Persistent Isolated C3 Hypocomplementemia as a Strong Predictor of End-Stage Kidney Disease in Lupus Nephritis 132
CKD therapy to improve outcomes of immune-mediated glomerular diseases 129
Cluster Analysis To Explore Clinical Subphenotypes Of Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss) 128
Slowly progressive ANCA-associated renal vasculitis. Clinico-pathological characterisation and outcome 128
Correction: Prognostic Factors and Long-Term Outcome with ANCA-Associated Kidney Vasculitis in Childhood 127
[Idiopathic retroperitoneal fibrosis]. FT La fibrosi retroperitoneale idiopatica 126
Long-term follow-up of mTOR inhibition for erdheim-chester disease 126
Clinical and histological findings at second but not at first kidney biopsy predict end-stage kidney disease in a large multicentric cohort of patients with active lupus nephritis 125
F-18-fluorodeoxyglucose positron emission tomography in the diagnosis and followup of idiopathic retroperitoneal fibrosis 122
New perspectives in eosinophilic granulomatosis with polyangiitis (EGPA): report of the first meeting of the European EGPA Study Group 122
Anca testing: where are we now? 122
Long-term disease control in granulomatosis with polyangiitis: Is low-dose rituximab the cure? 122
Chronic periaortitis with thoracic aorta and epiaortic artery involvement: a systemic large vessel vasculitis? 121
Idiopathic Mediastinal Fibrosis: a Systemic Immune-Mediated Disorder. A Case Series and a Review of the Literature 121
"Late" regressions of metastases from renal cancer after a period of disease progression continuing the same intermittent low dose immunotherapy regimen 120
Neutrophil Extracellular Traps in the Autoimmunity Context 120
Microarray evaluation of allergen-specific IgE in eosinophilic granulomatosis with polyangiitis 120
SARS-CoV-2 infection among patients with systemic autoimmune diseases 119
Occupational Exposures and Smoking in Eosinophilic Granulomatosis With Polyangiitis: A Case–Control Study 118
Chronic periaortitis: A clinical approach 117
The Sound of Interconnectivity; The European Vasculitis Society 2022 Report 117
Idiopathic retroperitoneal fibrosis: an update for nephrologists 116
Rituximab therapy for chronic periaortitis 115
Use of Biologics to Treat Relapsing and/or Refractory Eosinophilic Granulomatosis with Polyangiitis: data from a European Collaborative Study 114
Eotaxin-3 in Churg-Strauss syndrome: a clinical and immunogenetic study 114
Proteinuria selectivity index predicts response to rituximab in adults with minimal change disease and focal segmental glomerulosclerosis 113
[18F]-Fluorodeoxyglucose Positron Emission Tomography and Response to Therapy in Idiopathic Retroperitoneal Fibrosis 111
IgG4-related disease: a contemporary review 109
IgG4-related disease: Not just a matter of IgG4 109
A Candidate Gene Approach Identifies an IL33 Genetic Variant as a Novel Genetic Risk Factor for GCA 108
Jagged Ends on Multinucleosomal Cell-Free DNA Serve as a Biomarker for Nuclease Activity and Systemic Lupus Erythematosus 107
Aortitis and periaortitis: The puzzling spectrum of inflammatory aortic diseases 107
A cross-sectional study of the Birmingham Vasculitis Activity Score version 3 in systemic vasculitis 107
Sirolimus plus prednisone for Erdheim-Chester disease: An open-label trial 106
Collapsing Glomerulopathy as a Complication of Type I Interferon–Mediated Glomerulopathy in a Patient With RNASEH2B-Related Aicardi-Goutières Syndrome 106
Association of a TNFSF13B (BAFF) regulatory region single nucleotide polymorphism with response to rituximab in antineutrophil cytoplasmic antibody-associated vasculitis 105
Chronic periaortitis: a large-vessel vasculitis? 105
Adult idiopathic subglottic stenosis: a diagnostic and therapeutic challenge 105
2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Granulomatosis With Polyangiitis 103
Long-term outcome and prognosis of mixed histiocytosis (Erdheim-Chester disease and Langerhans Cell Histiocytosis) 103
Childhood-onset Erdheim-Chester Disease in the molecular era: clinical phenotype and long-term outcome of 21 patients 103
Scheduled rituximab maintenance reduces relapse rate in eosinophilic granulomatosis with polyangiitis 102
A misleading diagnosis of granulomatosis with polyangiitis disguising Whipple's disease 102
Totale 14.237
Salva come PNG Salva come JPEG
Categoria #
all - tutte 96.945
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 96.945
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021748 0 0 0 0 0 0 91 54 210 112 61 220
2021/20221.035 16 21 100 37 26 140 11 88 67 84 101 344
2022/20232.999 258 725 163 188 83 576 464 121 216 30 78 97
2023/20241.532 40 78 282 82 86 235 78 293 42 183 77 56
2024/20259.966 384 1.108 586 1.457 2.218 935 357 431 770 422 491 807
2025/202611.147 1.525 2.450 2.309 2.449 1.368 477 569 0 0 0 0 0
Totale 29.237